Article Versions Notes

Ejima R, Suzuki H, Tanaka T, Asano T, Kaneko MK, Kato Y. Development of a Novel Anti-CD44 Variant 6 Monoclonal Antibody C₄₄Mab-9 for Multiple Applications against Colorectal Carcinomas. International Journal of Molecular Sciences. 2023; 24(4):4007. https://doi.org/10.3390/ijms24044007

Ejima, Ryo, Hiroyuki Suzuki, Tomohiro Tanaka, Teizo Asano, Mika K. Kaneko, and Yukinari Kato. 2023. "Development of a Novel Anti-CD44 Variant 6 Monoclonal Antibody C₄₄Mab-9 for Multiple Applications against Colorectal Carcinomas" International Journal of Molecular Sciences 24, no. 4: 4007. https://doi.org/10.3390/ijms24044007

Ejima, R., Suzuki, H., Tanaka, T., Asano, T., Kaneko, M. K., & Kato, Y. (2023). Development of a Novel Anti-CD44 Variant 6 Monoclonal Antibody C₄₄Mab-9 for Multiple Applications against Colorectal Carcinomas. International Journal of Molecular Sciences, 24(4), 4007. https://doi.org/10.3390/ijms24044007